Dr. Martens Boots

Dr. Martens, often referred to as 'Docs' or 'Doc Martens,' is an iconic British footwear and apparel brand. The brand's origin dates back to 1945 in Germany, when Dr. Klaus Märtens created a unique air-cushioned sole to aid his recovery from a foot injury. The design was later perfected and licensed to the British shoe manufacturer R. Griggs Group Ltd., which officially launched the 1460 boot on April 1, 1960. Since then, the brand has evolved from utilitarian work boots to a global symbol of rebellious self-expression and subcultural fashion.

While the brand maintains a high-end 'Made in England' collection produced at its original Wollaston factory, the vast majority of its manufacturing was shifted to Asia in the early 2000s to maintain competitive pricing. Today, high-volume production is concentrated in countries like Vietnam, China, Thailand, and Laos. Despite these far-reaching manufacturing operations, the brand remains deeply rooted in its British heritage.

Ownership of Dr. Martens has transitioned from the founding Griggs family to institutional investors. In 2014, the private equity firm Permira acquired the brand, subsequently leading it to a public listing on the London Stock Exchange in 2021. As of 2024 and looking toward 2026, the brand is operated by Dr. Martens plc, a publicly traded company headquartered in London, ensuring its status as a cornerstone of British retail and global footwear culture.